Intellia Therapeutics, Inc. (LON: 0JBU)
London flag London · Delayed Price · Currency is GBP · Price in USD
10.26
-0.26 (-2.43%)
At close: Jan 31, 2025

Intellia Therapeutics Market Cap

Intellia Therapeutics has a market cap or net worth of 845.60 million as of January 31, 2025. Its market cap has decreased by -53.54% in one year.

Market Cap
845.60M
Enterprise Value
167.35M
Revenue
32.15M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.26

Market Cap Chart

Since May 6, 2016, Intellia Therapeutics's market cap has increased from 537.16M to 845.60M, an increase of 57.42%. That is a compound annual growth rate of 5.33%.

History

DateMarket Cap% Change
Jan 31, 2025845.60M-10.86%
Dec 31, 2024948.58M-55.75%
Dec 29, 20232.14B-13.15%
Dec 30, 20222.47B-62.02%
Dec 31, 20216.50B152.49%
Dec 31, 20202.57B375.35%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
AstraZeneca 175.89B
GSK plc 57.33B
Haleon 33.92B
Smith & Nephew 9.00B
Hikma Pharmaceuticals 5.08B
ConvaTec Group 5.06B
HUTCHMED (China) 1.88B
Oxford Nanopore Technologies 1.39B
Market Cap Rankings